The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

REPEAT: MARKET COMMENT: UK Stocks Close Lower After Roller Coaster Day

Thu, 07th Nov 2013 17:45

LONDON (Alliance News) - UK stocks closed lower Thursday following a volatile day of trading as investors reacted to a surprise rate cut by the European Central Bank and data from both the UK and US.

London's major indices opened flat to slightly lower Thursday as traders showed caution ahead of a series of much-anticipated data releases and central bank announcements.

With the Bank of England maintaining its record-low 0.50% interest rate and the size of its quantitative easing at GBP375 billion, in line with expectations, the first major release of the day did little to stir the markets.

The ECB's surprise 25-basis-point rate cut, however, sparked an stockmarket rally, as investors reveled in the prospect of even cheaper lending. UK and European stocks jumped on the news that the central bank was trimming its benchmark refinancing rate to a record low of 0.25% amid a slackening in inflation and sluggish economic growth in the eurozone.

"The combination both of October's unexpectedly large fall in inflation, the strength of the euro exchange rate, and growing concerns over liquidity conditions in the banking sector appears to have persuaded most members that some sort of reaction was necessary," said Jonathan Loynes, chief economist with the Capital Economics research group.

In the press conference in the immediate aftermath of the cut, ECB President Mario Draghi warned that, while "we may experience a prolonged period of low inflation," there was no threat of deflation in the currency bloc, rejecting any comparison with Japan, which has suffered from 15 years of deflation. Draghi declined to give a clear indication if or when the Central Bank will use quantitative easing, or asset purchases, as other central banks have, as a tool to spur demand, but did indicate that a further rate cut, presumably to zero, remains an available tool.

The equities rally was short-lived, however, as concerns about the outlook for the US Federal Reserve's USD85 billion-per-month stimulus programme helped to limit the upside for the markets. A Commerce Department report showed stronger-than-expected US third-quarter GDP growth, rasing the market concerns.

Spreadex's David White commented that "global markets whipsawed today in light of an unexpected rate cut by the ECB and then against a firm Q3 GDP figure from the States.

What began as a reason to bid equities was soon overtaken by a stronger one to sell," White said.

The report revealed that US gross domestic product rose by 2.8% in the third-quarter, compared to economist estimates for an increase of 2.0%. GDP growth accelerated from the 2.5% increase recorded in the second quarter, reflecting a deceleration in imports and acceleration in private inventory investment and in state and local government spending.

"Signs that the US economy slowed through the end of the third-quarter of 2013 have been washed away in one fell swoop, with the GDP report easily crushing expectations. In fact, only two economists of 87 polled suggested that the economy would grow by plus 2.8% or more," said Christopher Vecchio, currency analyst at DailyFX.

Added Paul Ashworth, Chief US Economist at Capital Economics, said, "overall, the pick-up in GDP growth will presumably add to the speculation that the Fed might yet begin tapering its asset purchases in December, even though the ECB is loosening monetary policy in the euro-zone."

"Frankly, it's hard to know exactly what precise improvement Fed officials are looking for after all the flip-flopping," Ashworth added. "October's payrolls figures, due out tomorrow, will provide a little more insight."

A separate report from the US Labor Department showed that initial jobless claims fell for the fourth straight week, coming in roughly in line with economist estimates. Initial jobless claims fell to 336,000 in the week ended November 2, a decrease of 9,000 from the previous week's revised figure of 345,000. Economists had expected claims to dip to 335,000 from the 340,000 originally reported for the previous week.

The FTSE 100 eventually closed down for a third consecutive day, falling 0.7% to close at 6,697.22. The FTSE 250 closed off 0.1% at 15,389.52, while the AIM All-Share index ended down 0.2% at 813.71.

Negative sentiment was shared in the US. At the London close, the DJIA was down 0.4% at 15,682.21, the S&P was down 0.7% at 1,757.87, and the Nasdaq was down 1.3% at 3,879.85.

Twitter was soaring. Shares in the social-media darling were trading above USD50.00 on their first day of trading, an increase of more than 90% from its offer price. The soaring debut on the New York Stock Exchange came just hours after Twitter said it was pricing its initial public offering at USD26.00 dollars a share, the third time it raised its IPO price since filing to go public.

In the UK, general retailers was among the biggest gaining FTSE 350 sector indices, up 0.5%, after Halfords, up 13% at 471.9968 pence, closed the day as the biggest gainer on the FTSE 250. The company reported higher sales and profits for the first half of its financial year, as the UK's growing passion for cycling and a revamp of its profits drove growth. The company said the good summer weather had driven up sales of cycles, while its recent revamp meant it had the stock and better products to meet the demand. Halfords reported a pretax profit of GBP44.6 million in the six months to September 27, up from GBP42.4 million a year earlier, and well ahead of a consensus forecast of GBP38.3 million. Revenues rose to GBP490.6 million, from GBP455.6 million.

Grainger, closing up 4.6% at 206.10p, was another big winner in the FTSE 250. The company revealed that it had swung to a profit for the full-year, as it positioned itself to take advantage of the UK housing recovery. Grainger said the UK government's efforts to help Britons buy homes through mortgaging financing schemes, as well as to boost development of the rental sector through the Build-to-Rent fund, were helping to strengthen the market. The company posted pretax profit of GBP64.3 million for the period ended September 30, compared with a GBP1.7 million loss a year earlier. The profit rise came as a result of efforts to reduce its debt, it said, which declined to GBP959 million from GBP1.19 billion a year earlier.

FTSE 250-listed Inmarsat closed down 4.9% at 678.8998p. It was the biggest loser on the mid-cap index. The satellite operator posted declining revenues in the third quarter. It said that several of its businesses were hurt by reduced military activity in Afghanistan, and that the launch of its Global Xpress satellite was delayed. The company posted total revenues of USD306.9 million, down from USD325.9 million in the previous year. Inmarsat also warned that in 2014, operating cost investments in the military radio spectrum band, L-Band, will coincide with a difficult outlook for its US government business. These factors are expected to combine to apply pressure on operating profits during 2014.

In the FTSE 100, Randgold Resources closed up 7.1% at 4,931.2p as the biggest gainer. The gold exploration and mining company revealed that its third-quarter sales and production had increased. While pretax profit fell 3.8% to USD126.6 million for the three months ended September 30, from USD131.6 million in the third-quarter 2012, it more than doubled its second-quarter figure of USD60.7 million.

After the market close, Royal Bank of Scotland said it had agreed to pay USD153.7 million to settle a US Securities and Exchange Commission probe into a USD2.2 billion residential mortgage-backed security the bank issued in 2007. The bank had already set aside a provision to cover the settlement. It had neither admitted nor denied the SEC allegations that its prospectus statement on the offering was misleading. RBS shares had closed down 0.9% at 324.95 pence prior to announcement.

In the forex market, the euro was hit hard Thursday. After slumping in the immediate aftermath of the ECB's rate cut decision, the strong US GDP figures sent the currency even lower. At the close of the UK equity trading, the euro was quoted at USD1.3390, having slipped to USD1.3294, its lowest point since September 16, in earlier trading.

The euro also was trading at GBP0.8333, having fallen to 0.8297, a low since mid-January, earlier in the day.

In the data calendar Friday, the Chinese trade balance is released overnight at 0200 GMT, ahead of German and French trade balances at 0700 GMT and 0745 GMT, respectively. UK goods and total trade balance numbers are scheduled for 0930 GMT.

In the US, October the much-anticipated nonfarm payrolls and unemployment rate figures are due to be released at 1330 GMT. US personal income, consumption, and spending data is expected at 1330 GMT.

Blue-chip Rolls-Royce is joined by FTSE 250-listed Hikma Pharmaceuticals, Bovis Homes and Tullett Prebon, amongst others, in releasing interim management statements Friday. Rentokil Initial provides a trading statement.

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
24 May 2022 07:09

Hikma's Siggi Olafsson stands down as CEO

(Sharecast News) - Drugmaker Hikma Pharmaceuticals revealed on Tuesday that chief executive Siggi Olafsson has resigned from both the role and the company's board of directors in order to pursue other opportunities.

Read more
13 May 2022 16:01

UK shareholder meetings calendar - next 7 days

Monday 16 May 
88 Energy LtdAGM
Allianz Technology Trust PLCAGM
Blackbird PLCAGM
BSF Enterprise PLCGM
Crossword Cybersecurity PLCAGM
DigitalBox PLCAGM
Ethernity Networks LtdAGM
Jubilee Metals Group PLCGM - re right of directors to allot equity securities for cash
Mast Energy Developments PLCAGM
Metal Tiger PLCAGM
Tuesday 17 May 
Accesso Technology Group PLCAGM
Capital & Regional PLCAGM
Chaarat Gold Holdings LtdAGM
Chesnara PLCAGM
Equals Group PLCAGM
European Assets Trust PLCAGM
Fidelity Japan Trust PLCAGM
Fintel PLCAGM
Fresnillo PLCAGM
GCP Asset Backed Income Fund LtdAGM
GENinCode PLCFull Year Results
Greggs PLCAGM
IQGeo Group PLCAGM
Kefi Gold & Copper PLCGM re share placing
Mears Group PLCAGM
Mercantile Investment Trust PLCAGM
Vitec Group PLCAGM
Vivo Energy PLCAGM
Wednesday 18 May  
ABCAM PLCAGM
abrdn PLCAGM in Edinburgh
Alliance Pharma PLCAGM
Burford Capital LtdAGM
Coats Group PLCAGM
CVC Credit Partners European Opportunities LtdAGM
EKF Diagnostics Holdings PLCAGM
Highcroft Investments PLCAGM
Impax Environmental Markets PLCAGM
JPMorgan American Investment Trust PLCAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Merchants Trust PLCAGM
PensionBee Group PLCAGM
Permanent TSB Group Holdings PLCAGM
PYX Resources LtdAGM
Riverstone Credit Opportunities Income PLCAGM
Schroder UK Public Private Trust PLCAGM
Science Group PLCAGM
Seplat Energy PLCAGM
TI Fluid Systems PLCAGM
Vesuvius PLCAGM
Thursday 19 May  
Bigblu Broadband PLCAGM
Brand Architekts Group PLCGM re takeover of InnovaDerma
Capital & Regional PLCAGM
Computacenter PLCAGM
Cornish Metals IncGM re equity raise
Dialight PLCAGM
Ebiquity PLCAGM
Eqtec PLCAGM
Essentra PLCAGM
Fevertree Drinks PLCAGM
Gamma Communications PLCAGM
Genuit Group PLCAGM
Headlam Group PLCAGM
Inchcape PLCAGM
InnovaDerma PLCGM re takeover by Brand Architekts
Irish Residential Properties REIT PLCAGM
K3 Business Technology Group PLCAGM
Light Science Tech Holdings PLCAGM
Live Co Group PLCGM
McColl's Retail Group PLCAGM
musicMagpie PLCAGM
Network International Holdings PLCAGM
Next PLCAGM
Pharos Energy PLCAGM
Property Franchise Group PLCAGM
Rotala PLCAGM
Smart Metering Systems PLCAGM
St James's Place PLCAGM
Tyman PLCAGM
Friday 20 May  
Bank of Cyprus Holdings PLCAGM
Croda International PLCAGM
Deliveroo PLCAGM
Georgia Capital PLCAGM
Hikma Pharmaceuticals PLCEGM re capital reduction
Keywords Studios PLCAGM
Real Estate Investors PLCAGM
Reckitt Benckiser Group PLCAGM
Resolute Mining LtdAGM
Restore PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 09:47

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 10:51

Signs of slowdown on the continent

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

SIGNS OF SLOWDOWN ON THE CONTINENT (1051 GMT)

Read more
5 May 2022 09:24

TOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drug

(Alliance News) - Shares in Hikma Pharmaceuticals PLC fell early Thursday, after the drugmaker downgraded guidance for its Generics business due to the delayed launch of a generic of the Xyrem treatment for narcolepsy.

Read more
5 May 2022 08:58

LONDON MARKET OPEN: Mondi and Shell lift FTSE 100 after strong updates

(Alliance News) - Stock prices in London opened sharply higher on Thursday after the US Federal reserve assuaged fears over further aggressive monetary policy tightening, while positive updates from Mondi and Shell boosted the FTSE 100.

Read more
5 May 2022 08:02

Hikma cuts 2022 generics guidance due to drug launch delay

(Sharecast News) - Hikma Pharmaceuticals cut guidance for its generics business on Thursday, citing a delay to a drug launch.

Read more
29 Apr 2022 17:44

IN BRIEF: Hikma says has not entered license agreement with Opiant

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, following a PR Newswire announcement issued on Friday. The release said Opiant and Hikma entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK.

Read more
29 Apr 2022 17:01

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

Read more
29 Apr 2022 09:09

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds.

Read more
29 Apr 2022 08:32

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

Read more
29 Apr 2022 08:25

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Read more
21 Apr 2022 16:06

UK dividends calendar - next 7 days

Friday 22 April 
JPMorgan Global Emerging Markets Income Trust PLCdividend payment date
Henderson Eurotrust PLCdividend payment date
Monday 25 April 
abrdn Smaller Cos Income Trust PLCdividend payment date
Tuesday 26 April 
Anglo American PLCdividend payment date
Anglo American PLCspecial dividend payment date
Invesco Asia Trust PLCdividend payment date
Wednesday 27 April 
Close Brothers Group PLCdividend payment date
Thursday 28 April 
4imprint Group PLCex-dividend date
AEW UK REIT PLCex-dividend date
AVI Japan Opportunity Trust PLCex-dividend date
Bakkavor Group PLCex-dividend date
Carr's Group PLCex-dividend date
Coats Group PLCex-dividend date
CQS Natural Resources Growth & Income PLCex-dividend date
CQS New City High Yield Fund Ltdex-dividend date
Derwent London PLCex-dividend date
Drax Group PLCex-dividend date
Ecofin Global Utilities & Infrastructure Trust PLCex-dividend date
Fresnillo PLCex-dividend date
Henderson Far East Income Trust PLCex-dividend date
Hikma Pharmaceuticals PLCdividend payment date
HSBC Holdings PLCdividend payment date
Kenmare Resourcesex-dividend date
LSL Property Services PLCex-dividend date
M&G PLCdividend payment date
M P Evans Group PLCex-dividend date
Mobius Investment Trust PLCex-dividend date
Morgan Advanced Materials PLCex-dividend date
Morgan Sindall Group PLCex-dividend date
Mortgage Advice Bureau (Holdings) PLCex-dividend date
Northamber plcdividend payment date
Porvair PLCex-dividend date
Reckitt Benckiser Group PLCex-dividend date
Rightmove PLCex-dividend date
Sabre Insurance Group PLCex-dividend date
Sabre Insurance Group PLCspecial ex-dividend date
Schroder Oriental Income Fund Ltdex-dividend date
Secure Income REIT PLCex-dividend date
Smart Metering Systems PLCdividend payment date
St James's Place PLCex-dividend date
Synthomer PLCex-dividend date
Tate & Lyle PLCspecial ex-dividend date
TT Electronics PLCex-dividend date
Tyman PLCex-dividend date
XP Power Ltddividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Apr 2022 14:37

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.